Polycystic ovary syndrome laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
Measurement of the plasma levels of several hormones is helpful in supporting the diagnosis of PCOS and especially in excluding other disorders. Determining the LH/FSH ratio of 3:1 is virtually diagnostic of PCOS; however, a normal ratio does not exclude the diagnosis, as LH levels fluctuate widely throughout the course of a day. Other androgens are measured to screen for other virilizing adrenal tumors. Fasting blood glucose is measured to look for diabetes; screening for lipid abnormalities is also employed. Testosterone is measured to exclude a virilizing tumor. Prolactin is measured to exclude a prolactinoma. Thyroid-stimulating hormone (TSH) is measured to rule out hypothyroidism
Measurement of the plasma levels of several hormones is helpful in supporting the diagnosis of PCOS and especially in excluding other disorders. Determining the [[Luteinizing hormone|LH]]/[[FSH]] ratio of 3:1 is virtually diagnostic of PCOS. However, a normal ratio does not exclude the diagnosis, as [[LH]] levels fluctuate widely throughout the course of a day. Other [[androgens]] are measured to screen for other virilizing adrenal tumors. [[Fasting blood sugar|Fasting blood glucose]] is measured to look for [[Diabetes mellitus|diabetes,]] screening for lipid abnormalities is also employed. [[Testosterone]] is measured to exclude a virilizing tumor. [[Prolactin]] is measured to exclude a [[prolactinoma]]. [[Thyroid-stimulating hormone]] (TSH) is measured to rule out [[hypothyroidism]].


==Laboratory Findings==
==Laboratory Findings==
Measurement of the plasma levels of several hormones is helpful in supporting the diagnosis of PCOS and especially in excluding other disorders. Determining the LH/FSH ratio of 3:1 is virtually diagnostic of PCOS; however, a normal ratio does not exclude the diagnosis, as LH levels fluctuate widely throughout the course of a day. Other androgens are measured to screen for other virilizing adrenal tumors. Fasting blood glucose is measured to look for diabetes; screening for lipid abnormalities is also employed. Testosterone is measured to exclude a virilizing tumor. Prolactin is measured to exclude a prolactinoma. Thyroid-stimulating hormone (TSH) is measured to rule out hypothyroidism.<ref>{{cite journal |author=Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L |title=Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia |journal=Rocz. Akad. Med. Bialymst. |volume=48 |issue= |pages=131-4 |year=2003 |pmid=14737959 |doi=}}</ref>
Measurement of the plasma levels of several hormones is helpful in supporting the diagnosis of PCOS and especially in excluding other disorders. Determining the [[Luteinizing hormone|LH]]/[[FSH]] ratio of 3:1 is virtually diagnostic of PCOS. However, a normal ratio does not exclude the diagnosis, as [[LH]] levels fluctuate widely throughout the course of a day. Other [[androgens]] are measured to screen for other virilizing adrenal tumors. [[Fasting blood sugar|Fasting blood glucose]] is measured to look for [[Diabetes mellitus|diabetes,]] screening for lipid abnormalities is also employed. [[Testosterone]] is measured to exclude a virilizing tumor. [[Prolactin]] is measured to exclude a [[prolactinoma]]. [[Thyroid-stimulating hormone]] (TSH) is measured to rule out [[hypothyroidism]].<ref>{{cite journal |author=Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L |title=Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia |journal=Rocz. Akad. Med. Bialymst. |volume=48 |issue= |pages=131-4 |year=2003 |pmid=14737959 |doi=}}</ref>
{| class="wikitable"
{| class="wikitable"
! colspan="2" |Harmone
! colspan="2" |Harmone
Line 32: Line 32:
|-
|-
| rowspan="5" |Androgens
| rowspan="5" |Androgens
|Sex hormone–binding globulin
|[[Sex hormone binding globulin|Sex hormone–binding globulin]]
|1.5 to 2.0 μg/mL
|1.5 to 2.0 μg/mL
|Decreased
|Decreased
|-
|-
|Androstenedione  
|[[Androstenedione]]
|75 to 205 ng/dL
|75 to 205 ng/dL
|Increased
|Increased
|-
|-
|Estrone:
|[[Estrone]]
|1.5 to 25.0 pg/mL
|1.5 to 25.0 pg/mL
|Increased
|Increased
|-
|-
|Dehydroepiandrosterone sulfate  
|[[Dehydroepiandrosterone sulfate]]
|50 to 450 μg/dL
|50 to 450 μg/dL
|Increased but are <800 μg/dL
|Increased but are <800 μg/dL
|-
|-
|17-Hydroxyprogesterone (follicular phase)
|[[17-Hydroxyprogesterone]] 
|15 to 70 ng/dL
|15 to 70 ng/dL
|Normal  
|Normal  
|-
|-
| colspan="2" |Fasting blood glucose
| colspan="2" |[[Fasting blood sugar|Fasting blood glucose]]
|<110 mg/dL
|<110 mg/dL
|>126mg/dL Indicates DM
|>126mg/dL Indicates DM

Revision as of 15:03, 3 August 2017

Polycystic ovary syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycystic ovary syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycystic ovary syndrome laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycystic ovary syndrome laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycystic ovary syndrome laboratory findings

CDC on Polycystic ovary syndrome laboratory findings

Polycystic ovary syndrome laboratory findings in the news

Blogs on Polycystic ovary syndrome laboratory findings

Directions to Hospitals Treating Polycystic ovary syndrome

Risk calculators and risk factors for Polycystic ovary syndrome laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Measurement of the plasma levels of several hormones is helpful in supporting the diagnosis of PCOS and especially in excluding other disorders. Determining the LH/FSH ratio of 3:1 is virtually diagnostic of PCOS. However, a normal ratio does not exclude the diagnosis, as LH levels fluctuate widely throughout the course of a day. Other androgens are measured to screen for other virilizing adrenal tumors. Fasting blood glucose is measured to look for diabetes, screening for lipid abnormalities is also employed. Testosterone is measured to exclude a virilizing tumor. Prolactin is measured to exclude a prolactinoma. Thyroid-stimulating hormone (TSH) is measured to rule out hypothyroidism.

Laboratory Findings

Measurement of the plasma levels of several hormones is helpful in supporting the diagnosis of PCOS and especially in excluding other disorders. Determining the LH/FSH ratio of 3:1 is virtually diagnostic of PCOS. However, a normal ratio does not exclude the diagnosis, as LH levels fluctuate widely throughout the course of a day. Other androgens are measured to screen for other virilizing adrenal tumors. Fasting blood glucose is measured to look for diabetes, screening for lipid abnormalities is also employed. Testosterone is measured to exclude a virilizing tumor. Prolactin is measured to exclude a prolactinoma. Thyroid-stimulating hormone (TSH) is measured to rule out hypothyroidism.[1]

Harmone Normal value PCOS Laboratory Findings
LH/FSH ratio <3;1 A ratio >3:1 is indicative of PCOS
Testosterone Free: 100 to 200 pg/dL

Total: 20 to 80 ng/dL

An elevated free testosterone level (200-400 pg/dL) is suggestive of PCOS,
Prolactin 3.8 to 23.2 μg/L A level >300 μg/L is virtually diagnostic of prolactinoma.
TSH 0.4 to 4.2 mIU/L Levels are normal in patients with PCOS
Androgens Sex hormone–binding globulin 1.5 to 2.0 μg/mL Decreased
Androstenedione 75 to 205 ng/dL Increased
Estrone 1.5 to 25.0 pg/mL Increased
Dehydroepiandrosterone sulfate 50 to 450 μg/dL Increased but are <800 μg/dL
17-Hydroxyprogesterone 15 to 70 ng/dL Normal
Fasting blood glucose <110 mg/dL >126mg/dL Indicates DM

References

  1. Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L (2003). "Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia". Rocz. Akad. Med. Bialymst. 48: 131–4. PMID 14737959.

Template:WS Template:WH